Linkerbot targets $6 billion valuation as it scales production of robotic hands for humanoids

English translation from Unibot. Source published 2026-05-07.
Beijing startup Linkerbot, which specializes in creating high-tech hands for humanoid robots, is valued at $3 billion after another round of investment. The company now sets a goal of reaching a capitalization of $6 billion.
Why are investors betting on robot hands?
The robotics market in China is booming, and the manipulator is becoming the key element determining the functionality of “humanoid” machines. According to founder Alex Zhou, the company already has more than 80% of the global market share in the high-degree-of-freedom hand segment. In the near future, Linkerbot plans to increase production from 5,000 to 10,000 units per month, which indicates an explosive growth in demand.
Technological advantage
Unlike many competitors, Linkerbot relies not on the robot’s walking, but on its “golden hands.” The company created the LinkerSkillNet platform, which digitizes human movements, turning them into ready-made skills for robots. More than 500 operations have already been recorded: from tightening screws and threading a needle to working with soft and fragile objects.
Technically, this is supported by its own developments: the company produces motors, gearboxes and joint modules using modern polymers. Their base model O6 weighs just 370g but can hold up to 50kg.
Market and strategy
Interestingly, Linkerbot's clients are not only manufacturers of full-fledged humanoids. Many factories simply install these manipulators on existing robotic arms to automate complex operations without purchasing an expensive $100,000 to $150,000 “humanoid” robot.
The startup also actively cooperates with scientific institutes and universities, having a staff of more than 400 employees and production sites in Beijing and Shenzhen.
The next step for Linkerbot will be to see if the growing demand for components can translate into sustainable funding and mass adoption of their technology. However, the timing and details of the new investment round remain secret.